Mar 18, 2020
KICVentures Appoints Ken Yamada as President & CEO of AxioMed
Oct 21, 2019
SpinalCyte to Present at the 2019 BIO Investor Forum
Sep 24, 2019
DiscGenics Announces Publication of Preclinical Data for Disc Degeneration Treatment in The Spine Journal
Aug 26, 2019
DiscGenics Receives FDA Fast Track Designation for Cell Therapy for Disc Degeneration
May 10, 2019
Understanding Causes and Treatments for a Ruptured Spinal Disc, Also Referred to as a Herniated Disc
May 01, 2019
Dr. Praveen Kadimcherla with Atlantic Spine Center has Alternatives to Spinal Fusion, Tips for Relief from Chronic Back Pain
Feb 04, 2019
SpinalCyte to Present at the 2019 BIO CEO & Investor Conference
Dec 14, 2018
Chronic Back, Neck Pain? All You Might Need Is a Little Jab
Dec 11, 2018
DiscGenics Receives Approval from Japanese Pharmaceuticals and Medical Devices Agency to Begin Clinical Evaluation of Non-Surgical Degenerative Disc Disease Treatment in Japan
Oct 16, 2018
Our Own Cells May Be Answer to Treating Chronic Back Pain
Oct 11, 2018
SpinalCyte Announces Publication Supporting the Therapeutic Effects of Fibroblast Cell Therapy in Disc Degeneration and Inflammation in The Spine Journal
Sep 24, 2018
SpinalCyte to Feature Fibroblast-Based Cell Therapy Results at the 2018 North American Spine Society Annual Meeting
May 23, 2018
Pivotal Clinical Trial Demonstrates Superiority of Anular Closure Compared to Standard Lumbar Discectomy
Apr 26, 2018
DiscGenics Announces First Patient Treated in U.S. Clinical Trial of IDCT for Degenerative Disc Disease
Mar 22, 2018
DiscGenics Presents Promising Preclinical Study Results at ORS 2018
Oct 03, 2017
DiscGenics Receives FDA Allowance of IND to Commence Clinical Study of Its Degenerative Disc Disease Therapy